NCT00772135View on ClinicalTrials.gov

Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

April 30, 2009

Conditions
Congenital Heart Disease
Interventions
DRUG

sildenafil citrate

capsule of 50 mg , 90 minutes before exercise study

Trial Locations (1)

0027

RECRUITING

Rikshospitalet University Hospital, Oslo

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Norwegian Foundation for Health and Rehabilitation

OTHER

collaborator

Pfizer

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT00772135 - Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients | Biotech Hunter | Biotech Hunter